Available options in the management of non-typhi Salmonella

Bibliography

• MEAD PS, SLUTSKER L, DIETZ V et al: Food-related illness and death in the United States. Emeig. Infect. Dis. (1999) 5:607–625.
   PubMed Web of Science ®Google Scholar
• ALTEKRUSE SF, COHEN ML, SWERDLOW DL: Emerging foodborne diseases. Emerg. Infect. Dis. (1997) 3:285–293.
   PubMed Web of Science ®Google Scholar
• MANDELL GL, BENNET JE, DOLIN YR: Enfermedades Infecciosas. Principios y practica (Volumen 2). Editorial Médica Panamericana, Madrid, Spain (2000):2846–2869.
   Google Scholar
• RUIZ M, RODRIGUEZ JC, ELIA M, ROYO G: Extra-intestinal infections caused by non-typhi Salmonella serotypes. 9 yrs'experience. Enferm. Infecc. Microbial. Clin. (2000) 18(5):219–22.
   Google Scholar
• SPERBER SJ, SCHLEUPNER CJ: Salmonellosis during infection with human immunodeficiency virus. Rev Infect. Dis. (1987) 9(5)::926–934.
   Google Scholar
• SIRINAVIN S, JAYANETRA P, LYANGKUL T: Predictors for extraintestinal infection in Salmonella enteritis in Thailand. Pediatr. Infect. Dis. (1988) 7:44–48.
   Google Scholar
• CRAVIOTO A, REYES RE, TRUJILLO F et al.: Risk of diarrhoea during the first year of life associated with initial and subsequent colonization by specifiic enteropathogens. Am. J. Epidemiol (1990) 131:886–909.
   PubMed Web of Science ®Google Scholar
• BUCHWALD DS, BLASER MJ: A review of human salmonellosis: II. Duration of excretion following infection with non-typhi Salmonella. Rev Infec. Dis. (1984) 6:345–356.
   Google Scholar
• MILLER SI, HOHMANN EL PEGUES DA: Especies de Salmonella, incluida Salmonella typhi. En: Enfermedades Infecciosas. Principios y practica (Volumen Mandell GL, Bennet JE, Dolin YR (Eds), Editorial Médica Panamericana, Madrid, Spain (2000):2846–2869.
   Google Scholar
• GOMEZ HF, CLEARY TG: Salmonella. In: Textbook of Pediatric Infectious Diseases (4th edit). Feigin RD, Cherry JD (Eds), WB Saunders Company, London, UK (1998):1321–1334.
   Google Scholar
• THRELFALL EJ, FISHER IS, WARD LR, TSCHAPE H, GERNER-SMIDT P: Harmonization of antibiotic susceptibility testing for Salmonella: results of a study by 18 national reference laboratories within the European Union-funded Enter-net group. Microb. Drug. Resist. (1999) 5(3):195–200.
   PubMed Web of Science ®Google Scholar
• HELMS M, VASTRUP P, GERNER-SMIDT P, MOLBAK K: Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium. Emeig. Infect. Dis. (2002) 8(5):490–495.
   PubMed Web of Science ®Google Scholar
• THRELFALL EJ, FISHER IS, BERGHOLD C et al.: Antimicrobial drug resistance in isolates of Salmonella enterica from cases of salmonellosis in humans in Europe in 2000: results of international multi-centre surveillance. Euro. Surveil]. (2003) 8(2):41–45.
   PubMedGoogle Scholar
• •An interesting article as it concerns a modern, multi-centre study of the antibiotic resistance of Salmonella throughout Europe.
   Google Scholar
• THRELFALL EJ, WARD LR, SKINNER JA, GRAHAM A: Antimicrobial drug resistance in non-typhoidal salmonellas from humans in England and Wales in 1999: decrease in multiple resistance in Salmonella enterica serotypes Typhimurium, Virchow, and Hadar. Microb. Drug. Resist. (2000) 6(4):319–325.
   PubMed Web of Science ®Google Scholar
• LEEGAARD TM, CAUGNAT DA, FROHOLM LO, HOIBY EA, LASSEN J: Emerging antibiotic resistance in Salmonella typhimurium in Norway. Epidemiol. Infect. (2000) 125(3):473–480.
   PubMed Web of Science ®Google Scholar
• VAN DUIJKEREN E, WANNET WJ, HOUVVERS DJ, VAN PELT W: Antimicrobial susceptibilities of salmonella strains isolated from humans, cattle, pigs, and chickens in the Netherlands from 1984 to 2001.f Clin. Microbiol. (2003) 41(8):3574–3578.
   Google Scholar
• STEPHEN JM, TOLEMAN MA, WALSH TR, JONES RN: Salmonella bloodstream infections: report from the SENTRY Antimicrobial Surveillance Program (1997-2001). Int. f Antimicrob. Agents (2003) 22(4):395–405.
   PubMed Web of Science ®Google Scholar
• SIRVENT E, RUIZ M, RODRIGUEZ JC,ROYO G: Serotipos y sensibilidad antibicitica del género Salmonella en Elche. Rev Esp. Quimioter. (2002) 15:55–60.
   PubMedGoogle Scholar
• RUIZ M, SIRVENT E, HERNANDEZ C, RODRIGUEZ JC, ROYO G: Evolution of resistance to quinolones in Salmonella enterica in our setting. Rev Esp. Quimiotec (1999) 12(4):366–368.
   Google Scholar
• HEURTIN-LE CORRE C, DONNIO PY, BONNIER M, TRAVERT ME LACOURT A, AVRIL JL: Growing incidence of nalidixic acid resistance and sensitivity to quinolones in Salmonella typhimurium strains isolated from man or animal. Pathol. Biol. (Paris) (1998) 46(8):587–590.
   PubMedGoogle Scholar
• HEURTIN-LE CORRE C, DONNIO PY, PERRIN M, TRAVERT ME AVRIL JL: Increasing incidence and comparison of nalidixic acid-resistant Salmonella enterica subsp. enterica serotype typhimurium isolates from humans and animals. f Clin. Microbiol. (1999) 37(1):266–269.
   PubMed Web of Science ®Google Scholar
• THRELFALL EJ et al.: Increase in multipleantibiotic resistance in nontyphoidal salmonellas from human in England and Wales: a comparison of data for 1984 and 1996. Microb. Drug. Resist. (1997) 3:263–266.
   PubMed Web of Science ®Google Scholar
• GUPTA A, FONTANA J, CROWE C et al, The National Antimicrobial Resistance Monitoring System PulseNet Working Group: emergence of multidrug-resistant Salmonella enterica serotype Newport infections resistant to expanded-spectrum cephalosporins in the United States.' Infect. Dis. (2003) 188(11):1707–1716.
   Google Scholar
• DIGRANES A, SOLBERG CO, SJURSEN H et al.: Antibiotic susceptibilities of blood culture isolates of Enterobacteriaceae from six Norwegian hospitals 1991-1992. APMIS (1997) 105:854–860.
   PubMed Web of Science ®Google Scholar
• GORDILLO ME, SINGH K, MURRAY BE: In vitro activity of azithromycin against bacterial enteric pathogens. Antimicrob. Agents. Chemother: (1993) 37(5):1203–1205.
   PubMed Web of Science ®Google Scholar
• RAKITA RM, JACQUES-PALAZ K, MURRAY BE: Intracellular activity of azithromycin against bacterial enteric pathogens. Antimicrob. Agents. Chemother: (1994) 38:1915–1921.
   PubMed Web of Science ®Google Scholar
• POIREL L, GUIBERT M, BELLAIS S, NAAS T, NORDMANN P: Integron- and carbenicillinase-mediated reduced susceptibility to amoxicillin-clavulanic acid in isolates of multidrug-resistant Salmonella enterica serotype typhimurium DT104 from French patients. Antimicrob. Agents Chemother: (1999) 43(5):1098–1104.
   PubMed Web of Science ®Google Scholar
• CEBRIAN L, SIRVENT E, RODRIGUEZ DIAZ JC, RUIZ M, ROYO G: Characterisation of Salmonella spp. mutants produced by exposure to various fluoroquinolones. Int. f Antimicrob. Agents. (2003) 22(2):134–139.
   PubMed Web of Science ®Google Scholar
• BAQUERO F, MARTINEZ-BELTRAN J, CANTON R: Criteria of the MENSURA group for the definition of the critical points of sensitivity to antibiotics. Enferm. Infecc. Microbiol. Clin. (1998) 16(2):85–92.
   PubMedGoogle Scholar
• PARRY CM: Antimicrobial drug resistance in Salmonella enterica. Carr: Opin. Infect. Dis. (2003) 16(5):467–472.
   PubMed Web of Science ®Google Scholar
• CHIU CH, WU TL, SU LH et al: The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype choleraesuis. N Engl. I Med. (2002) 346(6):413–419.
   PubMed Web of Science ®Google Scholar
• PAVIA AT, SHIPMAN LD, WELLS JC et al.: Epidemiologic evidence that prior antimicrobial exposures decreases resistance to infection by antimicrobial-sensitive Salmonella.' Infect. Dis. (1990) 161:255–260.
   Web of Science ®Google Scholar
• WORLD HEALTH ORGANIZATION: Control of Salmonella infections in animals and prevention of human foodborne Salmonella infections. Bull. World. Health. Organ. (1994) 72:831.
   PubMed Web of Science ®Google Scholar
• EDRINGTON TS, HARVEY RB, FARRINGTON LA, NISBET DJ: Evaluation of subtherapeutic use of the antibiotics apramycin and carbadox on the prevalence of antimicrobial-resistant Salmonella infection in swine. f Food. Prot. (2001) 64(12):2067–2070.
   Google Scholar
• PHILLIPS I, CASEWELL M, COX T et al.: Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. Antimicrob. Chemother. (2004) 53(1):28–52.
   Google Scholar
• THRELFALL EJ, FROST JA, WARD LR, ROWE B et al.: Increasing spectrum of resistance in multiresistant Salmonella typhimurium. Lancet (1996) 347:1053–1054.
   PubMed Web of Science ®Google Scholar
• CHIU CH, LIN TY, OU JT: A clinical trial comparing oral azithromycin, cefixime and no antibiotics in the treatment of acute uncomplicated Salmonella enteritis in children. I Paediatr. Child. Health. (1999) 35(4):372–374.
   PubMed Web of Science ®Google Scholar
• SIRINAVIN S, GARNER P: Antibiotics for treating salmonella gut infections. Cochrane Database Syst. Rev (2000) (2):CD001167.
   Google Scholar
• HOHMANN EL: Nontyphoidal salmonellosis. Clin. Infect. Dis. (2001) 32(2):263–269.
   PubMed Web of Science ®Google Scholar
• ••An excelent review article.
   Google Scholar
• DONABEDIAN H: Long-term suppression of Salmonella aortitis with an oral antibiotic. Arch. Intern. Med. (1989) 149:1452–1453.
   PubMedGoogle Scholar
• CHIAPPINI E, GALLI L, PECILE P, VIERUCCI A, DE MARTINO M: Results of a 5-year prospective surveillance study of antibiotic resistance among Salmonella enterica isolates and ceftriaxone therapy among children hospitalized for acute diarrhea. Clin. Ther. (2002) 24(10):1585–1594.
   PubMed Web of Science ®Google Scholar
• MOULIN F, SAUVE-MARTIN H, MARC E et al.: Ciprofloxacin after clinical failure of beta-lactam antibiotics in children with salmonellosis. Arch. Pediati: (2003) 10(7):608–614.
   PubMed Web of Science ®Google Scholar
• NOLAN CM, WHITE PCJ: Treatment of typhoidal carrier with amoxicilin. JAMA (1978) 239:2352–2354.
   PubMedGoogle Scholar
• SIRINAVIN S, THAVORNNUNTH J, SAKCHAINANONT B, BANGTRAKULNONTH A, CHONGTHAWONSATID S, JUNUMPORN S: Norfloxacin and azithromycin for treatment of nontyphoidal salmonella carriers. Clin. Infect. Dis. (2003) 37(5):685–691.
   PubMed Web of Science ®Google Scholar
• OSKOUI R, DAVIS W, GOMES M: Salmonella aortitis: a report of a sucessfully treated case with a comprehensive review of the literature. Arch. Intern. Med. (1993) 153:517–525.
   PubMedGoogle Scholar
• JACOBSON MA, HAHN SM, GEBERDING JL et al.: Ciprofloxacin for salmonella bacteremia in the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. (1989) 110:1027–1029.
   PubMed Web of Science ®Google Scholar
• CASADO JL, VALDEZATE S, CALDERON C et al: Zidovudine therapy protects against Salmonella bacteremia recurrence in human immunodeficiency virus-infected patients. J. Infect. Dis. (1999) 179(6):1553–1556.
   PubMed Web of Science ®Google Scholar
• PIDDOCK LJ, WHALE K, WISE R: Quinolone resistance in Salmonella: clinical experience. Lancet (1990) 335:1459.
   PubMed Web of Science ®Google Scholar
• BRAUMWALD E, FAUCI AS, KASPER DL, HAUSER SL, LONGO DL, JAMES ON JL: Harrison's Princioles of Internal Medicine (CD Rom) (i 1 gh edit). McGraw-Hill, New York, USA (2001).
   Google Scholar
• CRUMP JA, BARRETT TJ, NELSON JT,ANGULO FJ: Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae. Clin. Infect. Dis. (2003) 37(1):75–81.
   PubMed Web of Science ®Google Scholar
• •An interesting article as it raises the question of whether it would be advisable to modify the fluorquinolone break-points for Salmonella spp.
   Google Scholar
• AARESTRUP FM, WIUFF C, MOLBAK K, THRELFALL EJ: Is it time to change fluoroquinolone breakpoints for Salmonella spp.? Antimicrob. Agents. Chemother. (2003) 47(2):827–829.
   Google Scholar
• •An interesting article as it raises the question of whether it would be advisable to modify the fluorquinolone break-points for Salmonella spp.
   Google Scholar
• WORKMAN MR, PHILPOTT-HOWARD J, BRAGMAN S, BRITO-BABAPULLE F, BELLINGHAM AJ: Emergence of ciprofloxacin resistance during treatment of Salmonella osteomyelitis in three patients with sickle cell disease. J. Infect. (1996) 32 (1):27–32.
   PubMed Web of Science ®Google Scholar
• PERS C, SOGAARD P, PALLESEN L: Selection of multiple resistance in Salmonella enteritidis during treatment with ciprofloxacin. Scand. J. Infect. Dis. (1996) 28(5):529–531.
   PubMed Web of Science ®Google Scholar
• SIEPER J, FENDLER C, LAITKO S et al:No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study. Arthritis. Rheum. (1999) 42(7):1386–1396.
   PubMedGoogle Scholar
• MATTILA L, LEIRISALO-REPO M, PELKONEN P, KOSKIMIES S, GRANFORS K, SIITONEN A: Reactive arthritis following an outbreak of Salmonella Bovismorbificans infection. J. Infect. (1998) 36(3):289–295.
   PubMed Web of Science ®Google Scholar